Epstein-barr viral load monitoring may reduce risk after liver transplant

For patients undergoing liver transplant (LT), Epstein-Barr virus (EBV) viral load (VL) monitoring may reduce the incidence of posttransplant lymphoproliferative disease (PTLD), according to a study published online Jan. 17 in the Annals of Internal Medicine. Read the full story in Medical XPress.